NovaBay Pharmaceuticals: Q4 Earnings Insights
NovaBay Pharmaceuticals: Q4 Earnings Insights
NovaBay Pharmaceuticals (AMEX:NBY) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:05 PM.
NovaBay Pharmicals(美國證券交易所股票代碼:NBY)於2024年3月26日星期二下午4點05分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
NovaBay Pharmaceuticals beat estimated earnings by 30.0%, reporting an EPS of $-0.21 versus an estimate of $-0.3.
NovaBay Pharmicals的收益比預期高出30.0%,每股收益爲-0.21美元,而估計爲-0.3美元。
Revenue was up $84 thousand from the same period last year.
收入比去年同期增長了84,000美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.03 which was followed by a 8.0% drop in the share price the next day.
上個季度,該公司的每股收益高出0.03美元,隨後第二天股價下跌了8.0%。
Here's a look at NovaBay Pharmaceuticals's past performance:
以下是NovaBay Pharmicals過去的表現:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.40 | -0.55 | -0.91 | -0.17 |
EPS Actual | -0.37 | -1.27 | -0.85 | -1.47 |
Revenue Estimate | 3.55M | 3.67M | 3.20M | 5.10M |
Revenue Actual | 3.27M | 4.61M | 3.12M | 3.64M |
季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
---|---|---|---|---|
每股收益估算 | -0.40 | -0.55 | -0.91 | -0.17 |
實際每股收益 | -0.37 | -1.27 | -0.85 | -1.47 |
收入估算 | 3.55 米 | 3.67M | 3.20 米 | 5.10 米 |
實際收入 | 3.27 米 | 4.61M | 3.12 米 | 3.64 米 |
To track all earnings releases for NovaBay Pharmaceuticals visit their earnings calendar here.
要追蹤NovaBay Pharmicals發佈的所有業績,請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閱。
譯文內容由第三人軟體翻譯。